Bio-X
Showing 1-20 of 1,156 Results
-
Geoffrey Abrams, MD
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Abrams' research is focused on elucidating the pathobiology behind tendinoapthy and developing new treatment modalities for the disease. Specifically, his team is studying the role of micro-RNA as it relates to chronic inflammation and stem cell differentiation in the development and perpetuation of chronic tendinopathy.
-
Monther Abu-Remaileh
Assistant Professor of Chemical Engineering and of Genetics
Current Research and Scholarly InterestsWe study the role of the lysosome in metabolic adaptation using subcellular omics approaches, functional genomics and innovative biochemical tools. We apply this knowledge to understand how lysosomal dysfunction leads to human diseases including neurodegeneration, cancer and metabolic syndrome.
-
Ehsan Adeli
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Populations Sciences) and, by courtesy, of Computer Science and of Biomedical Data Science
Current Research and Scholarly InterestsMy research lies in the intersection of Machine Learning, Computer Vision, Healthcare, Ambient Intelligence, and Computational Neuroscience.
-
Nima Aghaeepour
Anesthesiology, Perioperative and Pain Medicine Professor and Professor of Pediatrics (Neonatology) and of Biomedical Data Science
BioNima Aghaeepour is a machine learning and artificial intelligence scientist and the Anesthesiology, Perioperative and Pain Medicine II Endowed Professor, and Professor of Pediatrics, and of Biomedical Data Science at Stanford University. His laboratory develops computational methods to study clinical and biological modalities in translational settings.
Dr. Aghaeepour primarily focuses on leveraging multiomics studies, wearable devices, and electronic health records to address clinical challenges in perioperative care and maternal and child health, with a particular focus on interventional settings including operating rooms, ICUs, labor and delivery, and NICUs. Prior to his faculty role, Dr. Aghaeepour earned his B.Sc. in Computer Science from the University of Tehran, followed by a Ph.D. in Bioinformatics from the University of British Columbia and a postdoctoral fellowship at Stanford University.
Dr. Aghaeepour is an alumnus of Stanford's Graduate School of Business Ignite program, a Biodesign Faculty Fellow, and a SPARK fellow and his laboratory provides training on the interface of academia and entrepreneurship. He regularly co-founds or serves on scientific advisory boards of startup companies and is committed to fostering entrepreneurship among his trainees through Stanford's unique programs. Beyond his scientific pursuits, Dr. Aghaeepour is an experienced pilot, skydiver, and wingsuiter. -
Biafra Ahanonu
Assistant Professor of Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsStudy the neural and molecular mechanisms of pain processing.
-
Aijaz Ahmed, MD
Professor of Medicine (Gastroenterology and Hepatology)
BioDr. Aijaz Ahmed is an internationally recognized hepatologist who is a board-certified specialist in gastroenterology and hepatology, transplant hepatology, and obesity medicine. He served as the Medical Director of the Adult Liver Transplant Program at Stanford University from 2008-2025. Dr. Ahmed graduated from Dow Medical College, Karachi, Pakistan. He completed his residency training in Internal Medicine at Brown University, Providence, RI and fellowship training in Gastroenterology and Hepatology at Stanford University.
Dr. Ahmed remains clinically active and has been instrumental in establishing a wide network of hepatology outreach clinics in remote and underserved regions of California and Nevada. In addition to his patient care responsibilities, Dr. Ahmed remains committed to the educational mission of Stanford University. He remains deeply interested in mentoring trainees and students at all levels from undergraduates to trainee physicians and junior colleagues. Dr. Ahmed has received several teaching awards during his career.
Dr. Ahmed’s research interests include: 1) multidisciplinary approach to metabolic dysfunction-associated steatotic liver disease (MASLD or ‘Fatty Liver’), 2) disparities in the management of chronic liver disease, 3) improving screening and management of hepatocellular carcinoma (HCC or ‘Liver Cancer’), and 4) outcomes research in MASLD, HCC, viral hepatitis, alcohol-related liver disease, and liver transplantation. He heads a busy and prolific outcomes research team. In addition, he collaborates with basic scientists and is participating in several translational research projects at Stanford University.
He has published his findings in research abstracts, clinical case reports, and peer-reviewed manuscripts in high impact factor medical journals. He has contributed by writing book chapters in textbooks. Dr. Ahmed and his team present their research at national and international conferences on a regular basis. For his clinical, teaching and research achievements, Dr. Ahmed has earned extensive recognition. He has been named as one of America’s Top Physicians by the Consumers’ Research Council of America on several occasions. -
Alex Aiken
Alcatel-Lucent Professor of Communications and Networking, Professor of Particle Physics and Astrophysics, and of Photon Science
BioAlex Aiken is the Alcatel-Lucent Professor of Computer Science at Stanford. Alex received his Bachelors degree in Computer Science and Music from Bowling Green State University in 1983 and his Ph.D. from Cornell University in 1988. Alex was a Research Staff Member at the IBM Almaden Research Center (1988-1993) and a Professor in the EECS department at UC Berkeley (1993-2003) before joining the Stanford faculty in 2003. His research interest is in areas related to programming languages.
-
Raag Airan
Associate Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Materials Science & Engineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsOur goal is to develop and clinically implement new technologies for high-precision and noninvasive intervention upon the nervous system. Every few millimeters of the brain is functionally distinct, and different parts of the brain may have counteracting responses to therapy. To better match our therapies to neuroscience, we develop techniques that allow intervention upon only the right part of the nervous system at the right time, using technologies like focused ultrasound and nanotechnology.
-
Teddy J. Akiki, MD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
Current Research and Scholarly InterestsDr. Akiki's research applies artificial intelligence to neuroimaging to improve psychiatric assessment and treatment selection, with a focus on depression, anxiety, and stress-related disorders. His program develops foundation models for functional MRI, pretrained on large neuroimaging datasets and adapted to predict treatment response and symptom trajectories in clinical populations. He also uses multimodal connectomics, combining structural, functional, and diffusion MRI, to characterize the circuit dysfunction underlying these disorders. His translational work centers on clinical trials of novel and repurposed treatments that target specific brain circuits, with neuroimaging used to measure circuit-level treatment effects and identify predictors of response. In parallel, he develops clinical decision support tools that translate an individual patient's neuroimaging into brain-based markers that clinicians can use in treatment planning.
-
Fernando Alarid-Escudero
Assistant Professor of Health Policy
Current Research and Scholarly InterestsFernando Alarid-Escudero builds computer simulation models that guide cancer prevention, screening, and treatment policy. He is a Principal Investigator of the NCI's CISNET colorectal and gastric cancer awards, where he leads the SimCRC model, which informs U.S. screening guidelines, and the DESCIPHR-GC model, and a co-investigator on bladder cancer. His lab also evaluates screening programs for Mexico and Chile and builds open-source tools (DARTH, ConVOI) that make models more reliable.
-
Ash A. Alizadeh, MD/PhD
Moghadam Family Professor
Current Research and Scholarly InterestsMy research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.
Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials. -
Nicolas Altemose
Assistant Professor of Genetics
Current Research and Scholarly InterestsThe Altemose Lab develops new experimental and analytical tools to study how chromatin proteins organize and regulate complex regions of the human genome.
-
Russ B. Altman
Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine, of Biomedical Data Science, Senior Fellow at the Stanford Institute for Human-Centered AI and Professor, by courtesy, of Computer Science
Current Research and Scholarly InterestsI refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/
-
Derek F. Amanatullah, M.D., Ph.D.
Associate Professor of Orthopaedic Surgery
BioDerek F. Amanatullah, M.D., Ph.D., is a board-certified hip and knee replacement surgeon at Stanford who cares for patients with advanced arthritis, and he is frequently sought out by patients whose joint replacements become infected, unstable, or persistently painful. He has been inducted into the Hip Society, the Knee Society, and the International Knee Society, prestigious invitation-only societies for the field’s most respected joint replacement surgeons. Each recommendation he makes rests on the evidence and on the skill, preparation, and coordination of the surgical team, an approach to patients with obesity that was featured in The New York Times. He is now editing a book on that approach for Springer Nature, titled “Arthroplasty and Obesity: Expanding Access and Optimizing Outcomes.”
His laboratory showed that some joint infections persist in a dormant state that standard tests miss, and that inflammation lingering in the joint after an apparently successful treatment predicts whether the infection will return. Infection also begins with behavior in the operating room. After the Stanford Biodesign Faculty Fellowship, he used computer vision to track the motion of circulating objects during surgery, work that earned his admission as a founder to StartX (the Stanford-affiliated startup accelerator) and the 2023 HLTH Surgical Transformation Award. That same technology now lets him study the motion of people and the behaviors in the operating room that shape the safety and efficiency of surgery.
He has published more than 250 peer-reviewed papers. They have been cited more than 8,500 times. He holds 30 issued U.S. patents. He has received more than 120 honors. They include the 2025 Charles A. Engh, Sr. Excellence in Hip Research Award from Current Concepts in Joint Replacement and the Hip Society, and the 2026 Board of Specialty Societies Research Support Fund Award from the American Academy of Orthopaedic Surgeons.
He co-edits the Journal of Bone and Joint Infection. He also serves as Associate Editor for Infection at The Journal of Bone and Joint Surgery and sits on the American Academy of Orthopaedic Surgeons Committee on Devices, Biologics, and Technology. He has mentored 236 trainees and junior colleagues, taught 12 courses, and given more than 400 lectures and presentations.
He is actively seeing patients at the Stanford Joint Replacement Center in Redwood City. -
Kanwaljeet S. Anand
Professor of Pediatrics (Pediatric Critical Care) and of Anesthesiology, Perioperative and Pain Medicine
On Partial Leave from 2026-10-26 To 2026-12-18Current Research and Scholarly InterestsDr. Anand is a translational clinical researcher who pioneered research on the endocrine-metabolic stress responses of infants undergoing surgery and developed the first-ever scientific rationale for pain perception in early life. This provided a framework for newer methods of pain assessment, numerous clinical trials of analgesia/anesthesia in newborns, infants and older children. His research focus over the past 30+ years has contributed fundamental knowledge about pediatric pain/stress, long-term effects of pain in early life, management of pain, mechanisms for opioid tolerance and withdrawal. Current projects in his laboratory are focused on developing biomarkers for repetitive pain/stress in critically ill children and the mechanisms underlying sedative/anesthetic neurotoxicity in the immature brain. He designed and directed many randomized clinical trials (RCT), including the largest-ever pediatric analgesia trial studying morphine therapy in ventilated preterm neonates. He has extensive experience in clinical and translational research from participating in collaborative networks funded by NIMH, NINDS, or NICHD, a track-record of excellent collaboration across multiple disciplines, while achieving success with large research teams like the Collaborative Pediatric Critical Care Research Network (CPCCRN). He played a leadership roles in CANDLE (Condition Affecting Neuro-Development & Learning in Early infancy) and other activities of the Urban Child Institute and UT Neuroscience Institute. More recently, he led the NeoOpioid Consortium funded by the European Commission, which collected data from 243 NICUs in 18 European countries.
-
Katrin Andreasson
Edward F. and Irene Thiele Pimley Professor of Neurology and Neurological Sciences
Current Research and Scholarly InterestsOur research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.
-
Jason Andrews
Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemology
Current Research and Scholarly InterestsOur laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.
-
Thomas P. Andriacchi
Professor of Mechanical Engineering and of Orthopaedic Surgery, Emeritus
Current Research and Scholarly InterestsProfessor Andriacchi's research focuses on the biomechanics of human locomotion and applications to medical devices, sports injury, osteoarthritis, the anterior cruciate ligament and low cost prosthetic limbs